NovaQuest

7 articles about NovaQuest

• Grünenthal and NovaQuest Enter Agreement to Advance the Resiniferatoxin Global Phase III Program in Osteoarthritis

  3/29/2022

  Grünenthal and NovaQuest announced that they have entered an agreement to advance the global clinical Phase III programme of Grünenthal's asset resiniferatoxin.

• Brickell Biotech Provides Update on Bodor Labs Complaint and Funding Agreement with NovaQuest

  10/30/2019

  Brickell initiated arbitration proceedings against Bodor Labs and Nicholas S. Bodor including a claim for tortious interference

• 

  Roivant Sciences Raises $200 Million, Bringing Its Valuation to $7 Billion

  11/13/2018

  Vivek Ramaswamy’s Roivant Sciences, the umbrella company to 14 Vant companies, including Datavant, Enzyvant Sciences, Urovant Sciences and others, raised another $200 million in equity financing.

• Catalyst Clinical Research, LLC To Accelerate Growth With The Acquisition By NovaQuest Capital Management, LLC's Private Equity Group

  10/31/2018

  Catalyst Clinical Research, LLC today announced that the private equity group of NovaQuest Capital Management, LLC

• VC Firm NovaQuest, Raises $459 Million Fund Focused on Pharma Opportunities

  11/1/2013

• Quintiles, Inc. Spinoff NovaQuest Banks $80 Million in Pooled Funder

  5/6/2013

• NovaQuest Receives Eli Lilly and Company's Highest Honor for Sustained Flawless Execution of Business-Critical Operations

  9/2/2008